16807

532998

LOTUSEYE

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

LOTUS EYE HOSP & INST L Share Price Today

LOTUS EYE HOSP & INST L is currently trading at ₹139.88, down by ₹0.09 from the previous close. The stock touched an intraday high of ₹140.90 and a low of ₹137.05 during the latest trading session. Over the past one year, LOTUS EYE HOSP & INST L has delivered a return of 93.23%, while the stock has gained 31.36% in the last one month.

LOTUS EYE HOSP & INST L performance

Today’s low Today’s high
₹ 137.05 ₹ 140.90
₹ 139.88
52 week low 52 week high
₹ 67.72 ₹ 147.00
₹ 139.88
Open Price ₹ 140.39
Prev. Close ₹ 139.98
Volume (Shares) 37979.00
Total traded value ₹ 53.12
Upper Circuit ₹ 167.97
Lower Circuit ₹ 111.99
info

Investment Returns

Over 1 Month 31.36% Over 3 Months 30.60% Over 6 Months 6.44% Over 1 Year 93.23%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

LOTUS EYE HOSP & INST L fundamentals


  • Market cap (Cr) 290.90
  • P/E Ratio (TTM) 3,466.25
  • Beta 0.75
  • Book Value / share 28.91
  • Return on equity 1.24%
  • EPS (TTM) 0.04
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) -0.32
info icon alternate text
  • Market cap (Cr) 291.00
  • P/E Ratio (TTM) 3,466.25
  • Beta 0.70
  • Book Value / share 28.91
  • Return on equity 1.24%
  • EPS (TTM) 0.04
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) -0.32
info icon alternate text

LOTUS EYE HOSP & INST L Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 13.61
Operating Expense 14.56
Net Profit -0.32
Net Profit Margin (%) -2.35
Earnings Per Share (EPS) -0.15
EBITDA 0.95
Effective Tax Rate (%) 33.33
Particulars DEC 2025 (Values in Cr)
Revenue 13.55
Operating Expense 14.17
Net Profit -0.26
Net Profit Margin (%) -1.91
Earnings Per Share (EPS) -0.13
EBITDA 0.88
Effective Tax Rate (%) 28.94
Particulars SEP 2025 (Values in Cr)
Revenue 13.04
Operating Expense 13.22
Net Profit 0.12
Net Profit Margin (%) 0.92
Earnings Per Share (EPS) 0.06
EBITDA 1.04
Effective Tax Rate (%) -57.14
Particulars JUN 2025 (Values in Cr)
Revenue 13.52
Operating Expense 12.97
Net Profit 0.54
Net Profit Margin (%) 3.99
Earnings Per Share (EPS) 0.26
EBITDA 1.67
Effective Tax Rate (%) 26.02
Particulars MAR 2025 (Values in Cr)
Revenue 11.51
Operating Expense 11.19
Net Profit 0.25
Net Profit Margin (%) 2.17
Earnings Per Share (EPS) 0.12
EBITDA 0.35
Effective Tax Rate (%) 70.23
Particulars MAR 2026 (Values in Cr)
Revenue 53.71
Operating Expense 54.94
Net Profit 0.08
Net Profit Margin (%) 0.14
Earnings Per Share (EPS) 0.04
EBITDA 4.56
Effective Tax Rate (%) 260.00
Particulars MAR 2025 (Values in Cr)
Revenue 49.56
Operating Expense 49.50
Net Profit 0.74
Net Profit Margin (%) 1.49
Earnings Per Share (EPS) 0.36
EBITDA 4.75
Effective Tax Rate (%) 46.37
Particulars MAR 2024 (Values in Cr)
Revenue 48.21
Operating Expense 45.51
Net Profit 2.91
Net Profit Margin (%) 6.03
Earnings Per Share (EPS) 1.40
EBITDA 7.84
Effective Tax Rate (%) 27.43
Particulars MAR 2023 (Values in Cr)
Revenue 47.04
Operating Expense 42.54
Net Profit 4.08
Net Profit Margin (%) 8.67
Earnings Per Share (EPS) 1.96
EBITDA 8.73
Effective Tax Rate (%) 27.78
Particulars MAR 2022 (Values in Cr)
Revenue 38.91
Operating Expense 35.69
Net Profit 2.98
Net Profit Margin (%) 7.65
Earnings Per Share (EPS) 1.44
EBITDA 6.72
Effective Tax Rate (%) 27.13
Particulars MAR 2025 (Values in Cr)
Book Value / Share 28.85
ROE % 1.24
ROCE % 2.99
Total Debt to Total Equity 0.04
EBITDA Margin 9.83
Particulars MAR 2024 (Values in Cr)
Book Value / Share 28.57
ROE % 4.97
ROCE % 7.06
Total Debt to Total Equity 0.02
EBITDA Margin 16.47
Particulars MAR 2023 (Values in Cr)
Book Value / Share 27.69
ROE % 7.27
ROCE % 10.18
Total Debt to Total Equity 0.02
EBITDA Margin 18.77
Particulars MAR 2022 (Values in Cr)
Book Value / Share 26.26
ROE % 5.55
ROCE % 7.81
Total Debt to Total Equity 0.02
EBITDA Margin 17.48
Particulars MAR 2021 (Values in Cr)
Book Value / Share 25.34
ROE % 3.02
ROCE % 4.01
Total Debt to Total Equity 0.01
EBITDA Margin 13.78
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 4.15
Total Assets 69.57
Total Liabilities 69.57
Total Equity 60.00
Share Outstanding 2
Price to Book Ratio 2.42
Return on Assets (%) 1.06
Return on Capital (%) 1.23
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 7.04
Total Assets 66.62
Total Liabilities 66.62
Total Equity 59.40
Share Outstanding 2
Price to Book Ratio 1.98
Return on Assets (%) 4.37
Return on Capital (%) 4.91
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 8.41
Total Assets 63.18
Total Liabilities 63.18
Total Equity 57.57
Share Outstanding 2
Price to Book Ratio 2.10
Return on Assets (%) 6.45
Return on Capital (%) 7.08
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 8.84
Total Assets 61.60
Total Liabilities 61.60
Total Equity 54.60
Share Outstanding 2
Price to Book Ratio 2.03
Return on Assets (%) 4.84
Return on Capital (%) 5.47
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 9.91
Total Assets 59.22
Total Liabilities 59.22
Total Equity 52.69
Share Outstanding 2
Price to Book Ratio 1.65
Return on Assets (%) 2.64
Return on Capital (%) 2.98
Particulars MAR 2025 (Values in Cr)
Net Income 1.37
Cash from Operations 3.32
Cash from Investing -3.99
Cash from Financing -1.59
Net change in Cash -2.88
Free Cash Flow 8.15
Particulars MAR 2024 (Values in Cr)
Net Income 4.00
Cash from Operations 6.94
Cash from Investing -3.68
Cash from Financing -3.37
Net change in Cash -1.37
Free Cash Flow 12.50
Particulars MAR 2023 (Values in Cr)
Net Income 5.65
Cash from Operations 5.79
Cash from Investing -2.19
Cash from Financing -1.70
Net change in Cash 0.48
Free Cash Flow 8.89
Particulars MAR 2022 (Values in Cr)
Net Income 4.10
Cash from Operations 5.25
Cash from Investing -3.93
Cash from Financing -1.57
Net change in Cash -1.09
Free Cash Flow 9.94
Particulars MAR 2021 (Values in Cr)
Net Income 1.91
Cash from Operations 3.02
Cash from Investing 0.48
Cash from Financing -0.31
Net change in Cash 2.89
Free Cash Flow 3.50
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTERPRISE LT 8467.10 62.24 12.85 121743.91 6680.00 8624.20
FORTIS MALAR HOSPITALS LIMITED 53.15 24.05 2.90 99.61 40.75 77.00
SHREE PACETRONIX LTD. 141.50 16.89 2.97 53.06 66.10 283.15
TRANSGENE BIOTEK LTD. 2.90 0.00 2.62 21.97 1.83 5.26
VIMTA LABS LTD. 478.55 35.16 6.23 2137.65 377.30 902.85
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTERPRISE LT 8467.10 81.09 12.21 121743.91 6680.00 8624.20
[-] 0.0 0.0 0.0 0.0 0.0 0.0
CHENNAI MEENAKSHI MULTISPECIAL 35.88 0.00 -8.73 26.80 30.30 57.48
KOVAI MEDICAL CENTER & HO 5770.70 25.82 4.78 6313.15 5010.00 6725.00

LOTUS EYE HOSP & INST L shareholding pattern

Holding
59.84%
40.13%
0.01%
87.15%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

LOTUS EYE HOSP & INST L Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
139.88 -0.07 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 131.80
  • 26 Days 118.20
  • 10 Days 125.50
  • 50 Days 115.50
  • 12 Days 123.80
  • 100 Days 113.90
  • 20 Days 119.80
  • 200 Days 109.10
138.39 PIVOT
First Support 133.58 First Resistance 144.79 Second Support 127.18 Second Resistance 149.60 Third Support 122.37 Third Resistance 156.00
RSI 74.91 ADX 43.16 MACD 5.64 Williams % R -8.66 Commodity Channel Index (CCI) 188.65
Date 2026-06-15 Week 66851.00 Same Day 151629.00 Month 23421.00
1 Year 0.76 3 Year 0.81
Over 1 Month
31.36% down
Over 1 Year
93.23% down
Over 3 Months
30.60% down
Over 3 Years
19.70% down
Over 6 Months
6.44% down
Over 5 Years
25.36% down

LOTUS EYE HOSP & INST L Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
18 Sep 2023 0.5 Final 18 Sep 2023 Equity shares
08 Sep 2022 0.5 Final 10 Sep 2022 Equity shares
08 Sep 2021 0.5 Final 11 Sep 2021 Equity shares
14 Sep 2018 0.5 Final 18 Sep 2018 Equity shares
02 Aug 2017 0.5 Final 04 Aug 2017 Equity shares
Dividend date Dividend amount Dividend type Record date Instrument type
18 Sep 2023 0.5 Final 18 Sep 2023 Equity shares
08 Sep 2022 0.5 Final 10 Sep 2022 Equity shares
08 Sep 2021 0.5 Final 11 Sep 2021 Equity shares
14 Sep 2018 0.5 Final 18 Sep 2018 Equity shares
02 Aug 2017 0.5 Final 04 Aug 2017 Equity shares

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Lotus Eye Hospital & Institute Ltd?

Answer Field

Lotus Eye Hospital & Institute Ltd share price is for NSE ₹ 139.88 & for BSE ₹ 141.05 as on Jun 16 2026 03:30 PM.

What is the Market Cap of Lotus Eye Hospital & Institute Ltd Share?

Answer Field

The market cap of Lotus Eye Hospital & Institute Ltd for NSE ₹ 290.90 & for BSE ₹ 0.00 as on Jun 16 2026 03:30 PM.

What is the 52 Week High and Low of Lotus Eye Hospital & Institute Ltd?

Answer Field

The 52 Week High and Low of Lotus Eye Hospital & Institute Ltd for NSE is ₹ 147.00 and ₹ 67.72 and for BSE is ₹ 147.60 and ₹ 68.00.

What is 1 year return for Lotus Eye Hospital & Institute Ltd?

Answer Field

The 1 year returns on the stock has been 93.23%.

What is the P/E Ratio of Lotus Eye Hospital & Institute Ltd Share?

Answer Field

As on Jun 16 2026 03:30 PM the price-to-earnings (PE) ratio for Lotus Eye Hospital & Institute Ltd share is 3466.25.

What is the PB ratio of Lotus Eye Hospital & Institute Ltd Share?

Answer Field

As on Jun 16 2026 03:30 PM, the price-to-book (PB) ratio for Lotus Eye Hospital & Institute Ltd share is 28.91.

How to Buy Lotus Eye Hospital & Institute Ltd Share?

Answer Field

You can trade in Lotus Eye Hospital & Institute Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Lotus Eye Hospital & Institute Ltd Share on Bajaj Broking App?

Answer Field

To buy Lotus Eye Hospital & Institute Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Lotus Eye Hospital & Institute Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|